ORMP

Oramed Pharmaceuticals Inc.

2.28 USD
-0.02 (-0.87%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Oramed Pharmaceuticals Inc. stock is down -1.72% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.84% of the previous 18 June’s closed higher than May.

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its flagship product is the ORMD-0801, an oral ingestible insulin capsule. It is also developing an oral glucagon-like peptide-1 capsule.